AUTO- HEMOLYTIC ANEMIA DISEASE: A SYSTEMATIC REVIEW OF FREQUENCY STUDIES: REVIEW ARTICLE

dc.contributor.authorHiyame Abdul Ridha Al-Awade
dc.contributor.authorBatool Shakir Abed Almjalawi
dc.contributor.authorBedour Ali Mohammed
dc.date.accessioned2025-12-31T15:35:56Z
dc.date.issued2022-02-19
dc.description.abstractIn this review of Auto-Immune Hemolytic Anemias (AIHAs) were a group of rare diseases defined by the obliteration of Red Blood Cells (RBCs) by cold or warm antibodies. There was no licensed action for (AIHA) at the time, and clinical studies on therapy and diagnosis were frequently dependent on certain national guidelines and expert judgments owing to a lack of recommendations. The (AIHA) in diagnosis, treatment and clinical practice. (AIHA) proves to be problematic. In addition, adequate understanding of the laboratory tests and pathophysiology done by the transfusion laboratory was required for a precise diagnosis
dc.formatapplication/pdf
dc.identifier.urihttps://scholarexpress.net/index.php/wbph/article/view/565
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/48839
dc.language.isoeng
dc.publisherScholar Express Journals
dc.relationhttps://scholarexpress.net/index.php/wbph/article/view/565/520
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.sourceWorld Bulletin of Public Health; Vol. 7 (2022): WBPH; 68-69
dc.source2749-3644
dc.subjectAuto Hemolytic Anemia Disease
dc.subjectRed Blood Cells and autoantibodies
dc.titleAUTO- HEMOLYTIC ANEMIA DISEASE: A SYSTEMATIC REVIEW OF FREQUENCY STUDIES: REVIEW ARTICLE
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
al-awade_2022_auto-_hemolytic_anemia_disease_a_systema.pdf
item.page.filesection.size
160.64 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections